Literature DB >> 25690978

Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A.

Susie Seok1, In Jeong Lyu2, Kyung Ah Park2, Sei Yeul Oh3.   

Abstract

PURPOSE: The purpose of this study was to describe the spectral domain optical coherence tomography (SD-OCT) characteristics of patients with retinal manifestations of mucopolysaccharidoses (MPSs) I, II, and IV A.
DESIGN: The research was a prospective, observational study.
METHODS: Fourteen consecutive patients with variants of MPS and 15 healthy subjects underwent ophthalmic assessments including fundus examinations and SD-OCT.
RESULTS: The fundus examinations revealed that four patients (two MPS I and two MPS II) had pigmented retinopathy in both eyes. In addition, one MPS II patient had cystoid macular edema and two MPS II patients had abnormal disc morphology. SD-OCT revealed thinning of the parafoveal photoreceptor inner segment/outer segment (IS/OS; two MPS I and one MPS II) and perifoveal photoreceptor IS/OS (two MPS I and five MPS II). All MPS I and II patients exhibited thickening of the central foveal external limiting membrane (ELM). Fundus and SD-OCT findings were normal in MPS IV A and healthy subjects. The foveal ELM was significantly thicker in MPS I and II patients than in healthy subjects (P =0 .000 and P =0 .000, respectively). The foveal IS/OS was significantly thinner in MPS I, II, and IV A patients than in healthy subjects (P = 0.000, P = 0.000, and P = 0.030, respectively). The foveal retinal pigment epithelium layer was also thinner in MPS II patients than in healthy subjects (P = 0.007)
CONCLUSIONS: In MPS, accumulation of glycosaminoglycans in retinal tissue induced retinal degeneration and pigmentary retinopathy. SD-OCT was a useful tool for detecting retinal pathology, particularly changes in ELM and IS/OS.

Entities:  

Keywords:  Mucopolysaccharidoses; Optical coherence tomography; Pigmentary retinopathy; Retinal layer thickness

Mesh:

Year:  2015        PMID: 25690978     DOI: 10.1007/s00417-015-2953-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.

Authors:  Farzin Forooghian; Catherine Cukras; Catherine B Meyerle; Emily Y Chew; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-30       Impact factor: 4.799

Review 2.  Ocular manifestations as key features for diagnosing mucopolysaccharidoses.

Authors:  C Gail Summers; Jane L Ashworth
Journal:  Rheumatology (Oxford)       Date:  2011-12       Impact factor: 7.580

3.  Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler).

Authors:  Kristina Teär Fahnehjelm; Alba Lucia Törnquist; Jacek Winiarski
Journal:  Acta Ophthalmol       Date:  2010-06-10       Impact factor: 3.761

Review 4.  Mild form of Maroteaux-Lamy syndrome: corneal histopathology and ultrastructure.

Authors:  N M Laver; M H Friedlander; I W McLean
Journal:  Cornea       Date:  1998-11       Impact factor: 2.651

5.  High-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome.

Authors:  Michael K Yoon; Royce W Chen; Thomas R Hedges; Vivek J Srinivasan; Iwona Gorczynska; James G Fujimoto; Maciej Wojtkowski; Joel S Schuman; Jay S Duker
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 Sep-Oct

6.  The outer limiting membrane (OLM) revisited: clinical implications.

Authors:  S Omri; B Omri; M Savoldelli; L Jonet; B Thillaye-Goldenberg; G Thuret; P Gain; J C Jeanny; P Crisanti; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2010-04-26

7.  Notch and Wnt signaling mediated rod photoreceptor regeneration by Müller cells in adult mammalian retina.

Authors:  Carolina Beltrame Del Debbio; Sudha Balasubramanian; Sowmya Parameswaran; Anathbandhu Chaudhuri; Fang Qiu; Iqbal Ahmad
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

8.  Central corneal thickness in mucopolysaccharidosis II and VI.

Authors:  Ulrike Kottler; Deniz Demir; Irene Schmidtmann; Michael Beck; Susanne Pitz
Journal:  Cornea       Date:  2010-03       Impact factor: 2.651

9.  Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse.

Authors:  H S Lazarus; W S Sly; J W Kyle; G S Hageman
Journal:  Exp Eye Res       Date:  1993-05       Impact factor: 3.467

10.  Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina.

Authors:  R A Pearson; A C Barber; E L West; R E MacLaren; Y Duran; J W Bainbridge; J C Sowden; R R Ali
Journal:  Cell Transplant       Date:  2010-01-20       Impact factor: 4.064

View more
  7 in total

1.  Response to: spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, IV A, and VI.

Authors:  Susie Seok; In Jeong Lyu; Kyung Ah Park; Sei Yeul Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-24       Impact factor: 3.117

2.  Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, IV A, and VI.

Authors:  Yuan-Chieh Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-27       Impact factor: 3.117

3.  Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies.

Authors:  Augusto Magalhães; Ana Maria Cunha; Rodrigo Vilares-Morgado; Elisa Leão-Teles; Esmeralda Rodrigues; Manuel Falcão; Ângela Carneiro; Jorge Breda; Fernando Falcão-Reis
Journal:  Case Rep Ophthalmol Med       Date:  2021-04-12

4.  Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.

Authors:  Heather G Mack; R C Andrew Symons; Gerard de Jong
Journal:  Am J Ophthalmol Case Rep       Date:  2017-10-04

5.  Retinal and optic nerve degeneration in α-mannosidosis.

Authors:  Juliane Matlach; Thea Zindel; Yasmina Amraoui; Laila Arash-Kaps; Julia B Hennermann; Susanne Pitz
Journal:  Orphanet J Rare Dis       Date:  2018-06-01       Impact factor: 4.123

6.  Recovery of Vision following Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II, Hunter Syndrome.

Authors:  Ryutaro Yamanishi; Natsuko Nakamura; Kazushige Tsunoda
Journal:  Case Rep Ophthalmol       Date:  2019-06-06

Review 7.  Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

Authors:  Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.